Author:
Berntsson Shala Ghaderi,Matsson Hans,Kristoffersson Anna,Niemelä Valter,van Duyvenvoorde Hermine A.,Richel-van Assenbergh Cindy,van der Klift Heleen M.,Casar-Borota Olivera,Frykholm Carina,Landtblom Anne-Marie
Abstract
We present the case of a male patient who was ultimately diagnosed with Becker muscular dystrophy (BMD; MIM# 300376) after the onset of muscle weakness in his teens progressively led to significant walking difficulties in his twenties. A genetic diagnosis was pursued but initial investigation revealed no aberrations in the dystrophin gene (DMD), although immunohistochemistry and Western blot analysis suggested the diagnosis of dystrophinopathy. Eventually, after more than 10 years, an RNA analysis captured abnormal splicing where 154 nucleotides from intron 43 were inserted between exon 43 and 44 resulting in a frameshift and a premature stop codon. Normal splicing of the DMD gene was also observed. Additionally, a novel variant c.6291–13537A>G in DMD was confirmed in the genomic DNA of the patient. The predicted function of the variant aligns with the mRNA results. To conclude, we here demonstrate that mRNA analysis can guide the diagnosis of non-coding genetic variants in DMD.
Subject
Genetics (clinical),Genetics,Molecular Medicine
Reference21 articles.
1. The importance of genetic diagnosis for Duchenne muscular dystrophy;Aartsma-Rus;J. Med. Genet.,2016
2. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management;Birnkrant;Lancet Neurol.,2018
3. The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations;Bladen;Hum. Mutat.,2015
4. Genomic answers for children: dynamic analyses of >1000 pediatric rare disease genomes;Cohen;Genet. Med.,2022
5. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing;Cummings;Sci. Transl. Med.,2017